Prostate cancer: Re-focusing on androgen receptor signaling
- 20 January 2007
- journal article
- review article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 39 (9) , 1562-1568
- https://doi.org/10.1016/j.biocel.2007.01.005
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- New drugs in prostate cancerCurrent Opinion in Urology, 2006
- Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survivalOncogene, 2006
- Germ-Line Mutation of NKX3.1 Cosegregates with Hereditary Prostate Cancer and Alters the Homeodomain Structure and FunctionCancer Research, 2006
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005
- Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesisNature, 2005
- Deletion, Methylation, and Expression of the NKX3.1 Suppressor Gene in Primary Human Prostate CancerCancer Research, 2005
- Survey of genetically engineered mouse models for prostate cancer: Analyzing the molecular basis of prostate cancer development, progression, and metastasisJournal of Cellular Biochemistry, 2005
- Pathological and molecular aspects of prostate cancerThe Lancet, 2003
- Alteration of the Tumor Suppressor Gene p53 in a High Fraction of Hormone Refractory Prostate CancerJournal of Urology, 1995
- Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate CancerNew England Journal of Medicine, 1995